Methods for the design of vasomotor symptom trials: The Menopausal Strategies: Finding lasting answers to symptoms and health network

Katherine M. Newton, Janet Carpenter, Katherine A. Guthrie, Garnet L. Anderson, Bette Caan, Lee S. Cohen, Kristine E. Ensrud, Ellen W. Freeman, Hadine Joffe, Barbara Sternfeld, Susan D. Reed, Sheryl Sherman, Mary D. Sammel, Kurt Kroenke, Joseph C. Larson, Andrea Z. Lacroix

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

OBJECTIVE: This report describes the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health network and methodological issues addressed in designing and implementing vasomotor symptom trials. METHODS: Established in response to a National Institutes of Health request for applications, the network was charged with conducting rapid throughput randomized trials of novel and understudied available interventions postulated to alleviate vasomotor and other menopausal symptoms. Included are descriptions of and rationale for criteria used for interventions and study selection, common eligibility and exclusion criteria, common primary and secondary outcome measures, consideration of placebo response, establishment of a biorepository, trial duration, screening and recruitment, statistical methods, and quality control. All trial designs are presented, including the following: (1) a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effectiveness of the selective serotonin reuptake inhibitor escitalopram in reducing vasomotor symptom frequency and severity; (2) a two-by-three factorial design trial to test three different interventions (yoga, exercise, and ω-3 supplementation) for the improvement of vasomotor symptom frequency and bother; and (3) a three-arm comparative efficacy trial of the serotonin-norepinephrine reuptake inhibitor venlafaxine and low-dose oral estradiol versus placebo for reducing vasomotor symptom frequency. The network's structure and governance are also discussed. CONCLUSIONS: The methods used in and the lessons learned from the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health trials are shared to encourage and support the conduct of similar trials and to encourage collaborations with other researchers.

Original languageEnglish
Pages (from-to)45-58
Number of pages14
JournalMenopause
Volume21
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Placebos
Health
Yoga
Citalopram
Controlled Clinical Trials
National Institutes of Health (U.S.)
Serotonin Uptake Inhibitors
Quality Control
Estradiol
Research Personnel
Outcome Assessment (Health Care)
Serotonin and Noradrenaline Reuptake Inhibitors
Venlafaxine Hydrochloride

Keywords

  • Clinical trial network
  • Exercise
  • Hot flashes
  • Menopause
  • Methodology
  • Study design
  • Vasomotor symptoms
  • Yoga

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Methods for the design of vasomotor symptom trials : The Menopausal Strategies: Finding lasting answers to symptoms and health network. / Newton, Katherine M.; Carpenter, Janet; Guthrie, Katherine A.; Anderson, Garnet L.; Caan, Bette; Cohen, Lee S.; Ensrud, Kristine E.; Freeman, Ellen W.; Joffe, Hadine; Sternfeld, Barbara; Reed, Susan D.; Sherman, Sheryl; Sammel, Mary D.; Kroenke, Kurt; Larson, Joseph C.; Lacroix, Andrea Z.

In: Menopause, Vol. 21, No. 1, 2014, p. 45-58.

Research output: Contribution to journalArticle

Newton, KM, Carpenter, J, Guthrie, KA, Anderson, GL, Caan, B, Cohen, LS, Ensrud, KE, Freeman, EW, Joffe, H, Sternfeld, B, Reed, SD, Sherman, S, Sammel, MD, Kroenke, K, Larson, JC & Lacroix, AZ 2014, 'Methods for the design of vasomotor symptom trials: The Menopausal Strategies: Finding lasting answers to symptoms and health network', Menopause, vol. 21, no. 1, pp. 45-58. https://doi.org/10.1097/GME.0b013e31829337a4
Newton, Katherine M. ; Carpenter, Janet ; Guthrie, Katherine A. ; Anderson, Garnet L. ; Caan, Bette ; Cohen, Lee S. ; Ensrud, Kristine E. ; Freeman, Ellen W. ; Joffe, Hadine ; Sternfeld, Barbara ; Reed, Susan D. ; Sherman, Sheryl ; Sammel, Mary D. ; Kroenke, Kurt ; Larson, Joseph C. ; Lacroix, Andrea Z. / Methods for the design of vasomotor symptom trials : The Menopausal Strategies: Finding lasting answers to symptoms and health network. In: Menopause. 2014 ; Vol. 21, No. 1. pp. 45-58.
@article{0ea3f889448d4d4d843808cd8b5dec69,
title = "Methods for the design of vasomotor symptom trials: The Menopausal Strategies: Finding lasting answers to symptoms and health network",
abstract = "OBJECTIVE: This report describes the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health network and methodological issues addressed in designing and implementing vasomotor symptom trials. METHODS: Established in response to a National Institutes of Health request for applications, the network was charged with conducting rapid throughput randomized trials of novel and understudied available interventions postulated to alleviate vasomotor and other menopausal symptoms. Included are descriptions of and rationale for criteria used for interventions and study selection, common eligibility and exclusion criteria, common primary and secondary outcome measures, consideration of placebo response, establishment of a biorepository, trial duration, screening and recruitment, statistical methods, and quality control. All trial designs are presented, including the following: (1) a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effectiveness of the selective serotonin reuptake inhibitor escitalopram in reducing vasomotor symptom frequency and severity; (2) a two-by-three factorial design trial to test three different interventions (yoga, exercise, and ω-3 supplementation) for the improvement of vasomotor symptom frequency and bother; and (3) a three-arm comparative efficacy trial of the serotonin-norepinephrine reuptake inhibitor venlafaxine and low-dose oral estradiol versus placebo for reducing vasomotor symptom frequency. The network's structure and governance are also discussed. CONCLUSIONS: The methods used in and the lessons learned from the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health trials are shared to encourage and support the conduct of similar trials and to encourage collaborations with other researchers.",
keywords = "Clinical trial network, Exercise, Hot flashes, Menopause, Methodology, Study design, Vasomotor symptoms, Yoga",
author = "Newton, {Katherine M.} and Janet Carpenter and Guthrie, {Katherine A.} and Anderson, {Garnet L.} and Bette Caan and Cohen, {Lee S.} and Ensrud, {Kristine E.} and Freeman, {Ellen W.} and Hadine Joffe and Barbara Sternfeld and Reed, {Susan D.} and Sheryl Sherman and Sammel, {Mary D.} and Kurt Kroenke and Larson, {Joseph C.} and Lacroix, {Andrea Z.}",
year = "2014",
doi = "10.1097/GME.0b013e31829337a4",
language = "English",
volume = "21",
pages = "45--58",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Methods for the design of vasomotor symptom trials

T2 - The Menopausal Strategies: Finding lasting answers to symptoms and health network

AU - Newton, Katherine M.

AU - Carpenter, Janet

AU - Guthrie, Katherine A.

AU - Anderson, Garnet L.

AU - Caan, Bette

AU - Cohen, Lee S.

AU - Ensrud, Kristine E.

AU - Freeman, Ellen W.

AU - Joffe, Hadine

AU - Sternfeld, Barbara

AU - Reed, Susan D.

AU - Sherman, Sheryl

AU - Sammel, Mary D.

AU - Kroenke, Kurt

AU - Larson, Joseph C.

AU - Lacroix, Andrea Z.

PY - 2014

Y1 - 2014

N2 - OBJECTIVE: This report describes the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health network and methodological issues addressed in designing and implementing vasomotor symptom trials. METHODS: Established in response to a National Institutes of Health request for applications, the network was charged with conducting rapid throughput randomized trials of novel and understudied available interventions postulated to alleviate vasomotor and other menopausal symptoms. Included are descriptions of and rationale for criteria used for interventions and study selection, common eligibility and exclusion criteria, common primary and secondary outcome measures, consideration of placebo response, establishment of a biorepository, trial duration, screening and recruitment, statistical methods, and quality control. All trial designs are presented, including the following: (1) a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effectiveness of the selective serotonin reuptake inhibitor escitalopram in reducing vasomotor symptom frequency and severity; (2) a two-by-three factorial design trial to test three different interventions (yoga, exercise, and ω-3 supplementation) for the improvement of vasomotor symptom frequency and bother; and (3) a three-arm comparative efficacy trial of the serotonin-norepinephrine reuptake inhibitor venlafaxine and low-dose oral estradiol versus placebo for reducing vasomotor symptom frequency. The network's structure and governance are also discussed. CONCLUSIONS: The methods used in and the lessons learned from the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health trials are shared to encourage and support the conduct of similar trials and to encourage collaborations with other researchers.

AB - OBJECTIVE: This report describes the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health network and methodological issues addressed in designing and implementing vasomotor symptom trials. METHODS: Established in response to a National Institutes of Health request for applications, the network was charged with conducting rapid throughput randomized trials of novel and understudied available interventions postulated to alleviate vasomotor and other menopausal symptoms. Included are descriptions of and rationale for criteria used for interventions and study selection, common eligibility and exclusion criteria, common primary and secondary outcome measures, consideration of placebo response, establishment of a biorepository, trial duration, screening and recruitment, statistical methods, and quality control. All trial designs are presented, including the following: (1) a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effectiveness of the selective serotonin reuptake inhibitor escitalopram in reducing vasomotor symptom frequency and severity; (2) a two-by-three factorial design trial to test three different interventions (yoga, exercise, and ω-3 supplementation) for the improvement of vasomotor symptom frequency and bother; and (3) a three-arm comparative efficacy trial of the serotonin-norepinephrine reuptake inhibitor venlafaxine and low-dose oral estradiol versus placebo for reducing vasomotor symptom frequency. The network's structure and governance are also discussed. CONCLUSIONS: The methods used in and the lessons learned from the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health trials are shared to encourage and support the conduct of similar trials and to encourage collaborations with other researchers.

KW - Clinical trial network

KW - Exercise

KW - Hot flashes

KW - Menopause

KW - Methodology

KW - Study design

KW - Vasomotor symptoms

KW - Yoga

UR - http://www.scopus.com/inward/record.url?scp=84891829011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891829011&partnerID=8YFLogxK

U2 - 10.1097/GME.0b013e31829337a4

DO - 10.1097/GME.0b013e31829337a4

M3 - Article

C2 - 23760428

AN - SCOPUS:84891829011

VL - 21

SP - 45

EP - 58

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 1

ER -